Sebastian Zenovia
Overview
Explore the profile of Sebastian Zenovia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
161
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rotaru A, Stafie R, Stratina E, Zenovia S, Nastasa R, Minea H, et al.
Life (Basel)
. 2025 Feb;
15(2).
PMID: 40003697
Metabolic dysfunction-associated steatotic liver disease (MASLD) challenges traditional paradigms by manifesting in lean individuals. The link between MASLD and inflammatory bowel disease (IBD) underscores the importance of the gut-liver axis...
2.
Huiban L, Stanciu C, Muzica C, Girleanu I, Avram R, Damian I, et al.
Medicina (Kaunas)
. 2024 Sep;
60(9).
PMID: 39336579
: Sustained virologic responses (SVRs) lead to a decrease in portal hypertension, the regression of fibrosis, and the improvement in the hepatic synthesis of procoagulant and anticoagulant factors. We aimed...
3.
Stratina E, Stanciu C, Nastasa R, Zenovia S, Stafie R, Rotaru A, et al.
Diagnostics (Basel)
. 2024 Jul;
14(14).
PMID: 39061612
Background And Aims: Increases in both the prevalence and severity of metabolic dysfunction-associated steatotic liver disease (MASLD) and obesity are closely related. Type 2 diabetes (T2DM) has been associated with...
4.
Igna R, Muzica C, Zenovia S, Minea H, Girleanu I, Huiban L, et al.
Arch Clin Cases
. 2024 Jul;
11(2):61-68.
PMID: 39015298
Acute on chronic liver failure (ACLF) is typically characterized by a rapid progression of liver failure in patients with liver cirrhosis and it is triggered by a precipitant factor, usually...
5.
Minea H, Singeap A, Sfarti C, Girleanu I, Chiriac S, Muzica C, et al.
J Clin Med
. 2023 Dec;
12(23).
PMID: 38068457
Introduction: Alcohol consumption (AC) represents a widespread cause of liver diseases affecting 10-20% of the population. The study aimed to evaluate the relationship between advanced liver fibrosis (ALF) measured by...
6.
Chiriac S, Sfarti C, Stanciu C, Cojocariu C, Zenovia S, Nastasa R, et al.
Life (Basel)
. 2023 Jun;
13(6).
PMID: 37374192
Background: Despite numerous advances that have aimed to increase the safety of endoscopic retrograde cholangiopancreatography (ERCP), post-ERCP pancreatitis (PEP) still remains a major issue. We aimed to assess the rate...
7.
Chiriac S, Sfarti C, Minea H, Stanciu C, Cojocariu C, Singeap A, et al.
Diagnostics (Basel)
. 2023 Apr;
13(7).
PMID: 37046447
Inflammatory bowel diseases (IBD) represent a global phenomenon, with a continuously rising prevalence. The strategies concerning IBD management are progressing from clinical monitorization to a targeted approach, and current therapies...
8.
Girleanu I, Trifan A, Huiban L, Muzica C, Petrea O, Singeap A, et al.
Diagnostics (Basel)
. 2023 Mar;
13(6).
PMID: 36980468
Atrial fibrillation is frequently diagnosed in patients with liver cirrhosis, especially in those with non-alcoholic steatohepatitis or alcoholic etiology. Anticoagulant treatment is recommended for thromboembolic protection in patients with atrial...
9.
Trifan A, Cuciureanu T, Nastasa R, Stratina E, Zenovia S, Muzica C, et al.
Life (Basel)
. 2023 Feb;
13(2).
PMID: 36836890
Chronic hepatitis C infection is a systemic disease that affects over 71 million patients all over the world and it is to be considered nowadays as a new cardiometabolic risk...
10.
Trifan A, Muzica C, Nastasa R, Zenovia S, Stratina E, Stafie R, et al.
Hepatol Commun
. 2023 Jan;
7(2):e0032.
PMID: 36691959
Background: Cirrhosis can be present undected for years prior to a symptomatic presentation. Early detection may result in improved outcomes. Data are lacking, however, regarding the yield of screening in...